FDA approves new multiple sclerosis treatment: Tecfidera

The U.S. Food and Drug Administration approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS). MS is a chronic, inflammatory, autoimmune disease of the central nervous system that disrupts communication between the brain and other parts of the body. For most people with MS, …

Continue reading